Should You Add Context Therapeutics Inc (CNTX) Stock to Your Portfolio Tuesday?

Context Therapeutics Inc (CNTX) is near the top in its sector according to InvestorsObserver. CNTX gets an overall rating of 46. That means it scores higher than 46% of stocks. Context Therapeutics Inc gets a 86 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

CNTX has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on CNTX!

See Full CNTX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Context Therapeutics Inc Stock Today?

Context Therapeutics Inc (CNTX) stock is up 8.91% while the S&P 500 is down -0.16% as of 10:39 AM on Tuesday, Oct 31. CNTX is higher by $0.09 from the previous closing price of $1.01 on volume of 4,308 shares. Over the past year the S&P 500 is up 7.45% while CNTX is down -12.70%. CNTX lost -$1.17 per share the over the last 12 months. Click Here to get the full Stock Report for Context Therapeutics Inc stock.